Evolving HTA frameworks to accelerate innovation
Innovation in the cancer treatment space offers great promise, but even when approved by the European Medicines Agency (EMA) and other national regulatory bodies, patients can still face protracted delays in accessing new treatments.
Uncertainties in the evidence base for pioneering therapies can lead to delays from health technology assessment (HTA) agencies and payers in securing reimbursement.
To accelerate progress here, HTA frameworks must evolve, says Clare Hague, Therapy Area Market Access Lead, Hematology at Janssen EMEA, speaking ahead of the upcoming eyeforpharma Barcelona 2020 conference. “We need...
Source: EyeForPharma - March 14, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Advancing through partnerships
If any reminder were needed of the power of collaboration in healthcare, it is the global efforts underway to stem the current coronavirus outbreak and to develop treatments for it.
Chris Round, Merck ’s Head of International Operations& Global Core Franchises, speaking to eyeforpharma ahead of his eyeforpharma Barcelona Conference 2020 keynote, mentions that Merck is lending its heft to industry efforts to help tackle the emergency. “The industry has shown what it is capable of with HIV and Ebola in the past, so I am hopeful that the industry can pull together very fast.”
Partnerships at scale at the i...
Source: EyeForPharma - March 14, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Advancing through partnerships
If any reminder were needed of the power of collaboration in healthcare, it is the global efforts underway to stem the current coronavirus outbreak and to develop treatments for it.
Chris Round, Merck ’s Head of International Operations& Global Core Franchises, speaking to eyeforpharma ahead of his eyeforpharma Barcelona Conference 2020 keynote, mentions that Merck is lending its heft to industry efforts to help tackle the emergency. “The industry has shown what it is capable of with HIV and Ebola in the past, so I am hopeful that the industry can pull together very fast.”
Partnerships at scale at the i...
Source: EyeForPharma - March 14, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Online hospitals – the journey from East to West
Imagine a world where you are sitting at your desk in the offices of a large company and you start to feel unwell. You take the lift to the ground floor to a vending machine in the lobby. You login and explain your symptoms to the machine. It gives you a diagnosis, prescribes your medication, you pay for it and it dispenses it on the spot. Far-fetched? No. This is the Ping An Good Doctor ‘One Minute Clinic’ launched by Chinese health-tech company Ping An Healthcare and Technology in April last year. Powered by Artificial Intelligence (AI), when a patient makes an inquiry, an algorithm identifies and sorts the symptom...
Source: EyeForPharma - March 13, 2020 Category: Pharmaceuticals Authors: Katie Osborne Source Type: news
Online hospitals – the journey from East to West
Imagine a world where you are sitting at your desk in the offices of a large company and you start to feel unwell. You take the lift to the ground floor to a vending machine in the lobby. You login and explain your symptoms to the machine. It gives you a diagnosis, prescribes your medication, you pay for it and it dispenses it on the spot. Far-fetched? No. This is the Ping An Good Doctor ‘One Minute Clinic’ launched by Chinese health-tech company Ping An Healthcare and Technology in April last year. Powered by Artificial Intelligence (AI), when a patient makes an inquiry, an algorithm identifies and sorts the symptom...
Source: EyeForPharma - March 13, 2020 Category: Pharmaceuticals Authors: Katie Osborne Source Type: news
Building an innovation culture
Anyone pushing the frontiers of innovation has to accept that failure is a part of the process. This should not be a novel concept for pharma, yet in some ways it still is. Pharmaceutical businesses are good at it in some domains but not others, says Sebastian Guth, President, Americas Region, Bayer. “As a pharma industry, we spend tens of billions of dollars each year in clinical trials, yet the probability of success for bringing any of those molecules to a patient is well below 50%. When developing innovation using AI, we often talk about significantly smaller investments and financial risk s than in clinical trials ...
Source: EyeForPharma - March 12, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Building an innovation culture
Anyone pushing the frontiers of innovation has to accept that failure is a part of the process. This should not be a novel concept for pharma, yet in some ways it still is. Pharmaceutical businesses are good at it in some domains but not others, says Sebastian Guth, President, Americas Region, Bayer. “As a pharma industry, we spend tens of billions of dollars each year in clinical trials, yet the probability of success for bringing any of those molecules to a patient is well below 50%. When developing innovation using AI, we often talk about significantly smaller investments and financial risk s than in clinical trials ...
Source: EyeForPharma - March 12, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Towards the sales force of the near future
Let this statistic sink in: Around 70% of HCPs are now digital natives. It ’s just one factor that is changing the way doctors want to interact with pharma today.
Their needs and priorities are evolving fast and pharma sales must adapt. Face-to-face meetings are a dwindling preference from a cohort of doctors who are under greater time pressure, want clinically relevant insights at their convenience and who are increasingly turning to online solutions. The desire for more online and remote engagement is clear, says Mads Bjarni-Kornbech, VP, Marketing& Communications atAgnitio. “Our fastest growing channel is ...
Source: EyeForPharma - March 4, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Towards the sales force of the near future
Let this statistic sink in: Around 70% of HCPs are now digital natives. It ’s just one factor that is changing the way doctors want to interact with pharma today.
Their needs and priorities are evolving fast and pharma sales must adapt. Face-to-face meetings are a dwindling preference from a cohort of doctors who are under greater time pressure, want clinically relevant insights at their convenience and who are increasingly turning to online solutions. The desire for more online and remote engagement is clear, says Mads Bjarni-Kornbech, VP, Marketing& Communications at Agnitio. “Our fastest growing channel is...
Source: EyeForPharma - March 4, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news
Into pharma's roaring twenties
“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking in darkness,...
Source: EyeForPharma - January 14, 2020 Category: Pharmaceuticals Authors: Paul Simms Source Type: news
Into pharma's roaring twenties
“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back down to ground level just in time to see the man draw back his fist in anger, and then.And then.With a piercing shriek, he lunged straight at my jaw –”Do you ever wake from a dream, marvelling at the inventiveness and detail of your subconscious mind? That disorienting moment where you lie blinking in darkness,...
Source: EyeForPharma - January 14, 2020 Category: Pharmaceuticals Authors: Paul Simms Source Type: news
